GH Research PLC Stock Analysis & AI Score
GH Research PLC (GHRS) has an ST Score of 56.0 (B-), driven by its Financial Strength (A+) and held back by its Growth (F). Analysts rate it Buy with a $48.83 price target (+99.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
GH Research PLC (GHRS) has an ST Score of 56.0 (B-), driven by its Financial Strength (A+) and held back by its Growth (F). Analysts rate it Buy with a $48.83 price target (+99.7% upside).
- Strongest
- Financial StrengthA+
- Weakest
- GrowthF
All factor grades
- Financial StrengthA+
- ProfitabilityA-
- ForecastA-
- MomentumB+
- ValuationB-
- GrowthF
- Piotroski1/9
Contact
GHRS stock: frequently asked questions
What is GHRS's ST Score?
GH Research PLC (GHRS) has an ST Score of 56.0 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GHRS a buy, hold, or sell?
Analysts rate GHRS a Buy, with a price target of $48.83 (+99.7% vs the current price). Our ST Score grades it B- (56.0/100). The ST Score is a data-driven signal, not a recommendation.
What are GHRS's factor grades?
Valuation B-, Profitability A-, Financial Strength A+, Momentum B+, Growth F, Forecast A-.
What is GHRS's valuation grade?
GH Research PLC (GHRS) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GHRS's growth grade?
GH Research PLC (GHRS) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GHRS's profitability grade?
GH Research PLC (GHRS) earns a profitability grade of A-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GHRS's financial strength grade?
GH Research PLC (GHRS) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GHRS?
The average analyst price target for GH Research PLC (GHRS) is $48.83 from 9 analysts, which is +99.7% versus the recent price of $24.45.
What is GHRS's Piotroski score?
GH Research PLC (GHRS) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.